礼来上调海外市场药品价格，以弥补美国市场降价损失_老虎社区_美港股上老虎

礼来上调海外市场药品价格，以弥补美国市场降价损失

智通财经2025-08-15

美国白宫为降低国内药价的行动，正在推高欧洲的药品价格。智通财经APP获悉，总部位于印第安纳州的礼来(LLY.US)周四宣布，将上调其在海外市场的药品官方定价。礼来表示，“为了使美国的药价下降，政府和医疗系统在欧洲等其他发达市场所支付的药品价格需要提高。”这一表态正值白宫对大型制药企业施压之际。根据美国政府基于2022年数据发布的报告，美国品牌药的官方定价比其他富裕国家高出422%。上月底，总统...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2559677799?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","is_english":false,"pubTime":"2025-08-15 06:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559677799","market":"hk","top_or_hot":-1,"title":"礼来上调海外市场药品价格，以弥补美国市场降价损失","media":"智通财经","content":"<div>\n<p>美国白宫为降低国内药价的行动，正在推高欧洲的药品价格。智通财经APP获悉，总部位于印第安纳州的礼来(LLY.US)周四宣布，将上调其在海外市场的药品官方定价。礼来表示，“为了使美国的药价下降，政府和医疗系统在欧洲等其他发达市场所支付的药品价格需要提高。”这一表态正值白宫对大型制药企业施压之际。根据美国政府基于2022年数据发布的报告，美国品牌药的官方定价比其他富裕国家高出422%。上月底，总统...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1329866.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>礼来上调海外市场药品价格，以弥补美国市场降价损失</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n礼来上调海外市场药品价格，以弥补美国市场降价损失\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-15 06:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1329866.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国白宫为降低国内药价的行动，正在推高欧洲的药品价格。智通财经APP获悉，总部位于印第安纳州的礼来(LLY.US)周四宣布，将上调其在海外市场的药品官方定价。礼来表示，“为了使美国的药价下降，政府和医疗系统在欧洲等其他发达市场所支付的药品价格需要提高。”这一表态正值白宫对大型制药企业施压之际。根据美国政府基于2022年数据发布的报告，美国品牌药的官方定价比其他富裕国家高出422%。上月底，总统...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1329866.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2491050154.USD","symbol_name":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1329866.html","article_id":"2559677799","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559677799","pubTimestamp":1755208800,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"美国白宫为降低国内药价的行动，正在推高欧洲的药品价格。智通财经APP获悉，总部位于印第安纳州的礼来周四宣布，将上调其在海外市场的药品官方定价。礼来表示，“为了使美国的药价下降，政府和医疗系统在欧洲等其他发达市场所支付的药品价格需要提高。”礼来称，英国患者仍可通过国家医疗服务体系获得该药。受消息提振，礼来股价周四上涨3.62%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU0079474960.USD":"联博美国增长基金A","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","BK4581":"高盛持仓","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LLY":"礼来","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","BK4534":"瑞士信贷持仓","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4516":"特朗普概念","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H"},"translate_title":"Eli Lilly (LLY.US) raises drug prices in overseas markets to make up for the loss of price cuts in the US market","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/db0ed3fc0b69907b4eb3cf5869257cfb","symbols_score_info":{"LLY":1},"content_text":"美国白宫为降低国内药价的行动，正在推高欧洲的药品价格。智通财经APP获悉，总部位于印第安纳州的礼来(LLY.US)周四宣布，将上调其在海外市场的药品官方定价。礼来表示，“为了使美国的药价下降，政府和医疗系统在欧洲等其他发达市场所支付的药品价格需要提高。”这一表态正值白宫对大型制药企业施压之际。根据美国政府基于2022年数据发布的报告，美国品牌药的官方定价比其他富裕国家高出422%。上月底，总统特朗普向礼来首席执行官David Ricks及约十几家大型制药公司CEO致信，要求在9月底前下调部分药品在美国的价格，否则政府将“动用一切手段保护美国家庭”。礼来的此番举措似乎是在回应白宫的要求，但其实际意义尚难评估。通常，政府和保险机构并不会按目录价全额支付药费，因此此次涨价对公司在欧洲及其他海外市场收益的具体影响仍不明确。特朗普政府一直推动“最惠国价格”政策，即将美国处方药价格与其他富裕国家的最低价挂钩。今年7月底，特朗普在致制药公司CEO的信中要求，将已上市药品在美国的价格降至“最惠国”水平，并要求新上市药品在所有其他支付方中同样执行该低价。通过上调欧洲药价，礼来或可在一定程度上抵消因下调美国价格带来的盈利冲击，更重要的是，欧洲价格的提升也可能抬高白宫拟采用的“最惠国价格”基准。具体来看，礼来将英国市场最大片剂规格的Mounjaro(其用于治疗2型糖尿病及肥胖的重磅药物)目录价上调170%。该药在美国以Zepbound和Mounjaro两个品牌销售，在英国则统一使用Mounjaro品牌。此外，低剂量版本的英国目录价也将上调：最低剂量涨幅为45%，较高剂量涨幅则在96%至138%之间。礼来称，英国患者仍可通过国家医疗服务体系获得该药。受消息提振，礼来股价周四上涨3.62%。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}